Literature DB >> 9361515

Benign liver tumors: differential diagnosis and indications for surgery.

A Weimann1, B Ringe, J Klempnauer, P Lamesch, K F Gratz, M Prokop, H Maschek, G Tusch, R Pichlmayr.   

Abstract

The differential diagnosis for hemangioma, focal nodular hyperplasia (FNH), and hepatocellular adenoma may be difficult. Reliable diagnosis is mandatory for the decision of whether to apply surgery or observation. Experience with long-term observation in nonoperated patients with hemangioma and FNH is limited. A group of 437 patients from a single institution were analyzed with regard to a diagnostic algorithm, the indications for surgery, and observation. There were 238 hemangiomas, 150 cases of FNH, 44 adenomas, and 5 mixed tumors. Of the 437 patients, 173 underwent surgery; 103 with hemangioma and 54 with FNH were observed at our own institution, whereas 117 patients underwent follow-up elsewhere or were lost. Among the operated patients with confirmed histology, a good diagnostic yield was found for a combination of ultrasonography (US), contrast (bolus)-enhanced computed tomography (CT), and labeled red blood cell (RBC) scanning: sensitivity 85.7%, specificity 100%, positive predictive value (PPV) 100%, negative predictive value (NPV) 81.8%, and accuracy 91.3%. For FNH and combination of US and CT plus cholescintigraphy showed a sensitivity 82.1%, specificity 97.1%, PPV 95.8%, NPV 84.6%, and accuracy 90.3%. Surgical mortality was 0.6%. Observation of patients with hemangioma and FNH for a median of 32 months revealed no increase in tumor size in 80% and a decrease in fewer than 7%. There was no tumor rupture and no evidence of malignant transformation. We concluded that liver hemangioma and FNH can be differentiated from adenoma with high sensitivity, specificity, and accuracy by labeled RBC scanning and cholescintigraphy in combination with US and contrast-enhanced CT. In the case of symptoms or an equivocal diagnosis with respect to adenoma or hepatocellular carcinoma, surgery can be performed with very low risk. Because in asymptomatic patients with observed hemangioma or FNH no increase of tumor size can be expected for many years, the indications for surgery must be carefully evaluated.

Entities:  

Mesh:

Year:  1997        PMID: 9361515     DOI: 10.1007/s002689900337

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  59 in total

1.  Etiology and management of hemmorrhage in spontaneous liver rupture: a report of 70 cases.

Authors:  Zhe-Yu Chen; Qing-Hui Qi; Zuo-Liang Dong
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

Review 2.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

3.  Major hepatectomy for a symptomatic giant liver cavernous hemangioma.

Authors:  Edoardo de Werra; Giuseppe Maria Ettorre; Giovanni Battista Levi Sandri; Marco Colasanti; Emanuele Felli; Giovanni Vennarecci
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

Review 4.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

5.  [Sequential liver scintigraphy in the differential diagnosis of focal nodular hyperplasia].

Authors:  J Bucerius
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

6.  Malignant transformation of hepatic adenoma with recurrence after resection.

Authors:  Kenneth A Larson; Sharon M Weber; Yuman Fong; Leslie H Blumgart
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

7.  Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.

Authors:  Edouard Reizine; Giuliana Amaddeo; Frederic Pigneur; Laurence Baranes; François Legou; Sebastien Mulé; Benhalima Zegai; Vincent Roche; Alexis Laurent; Alain Rahmouni; Julien Calderaro; Alain Luciani
Journal:  Eur Radiol       Date:  2018-05-02       Impact factor: 5.315

Review 8.  A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature.

Authors:  Theodoros Petsas; Athanassios Tsamandas; Irene Tsota; Dionisios Karavias; Chrysoula Karatza; Vassilios Vassiliou; Dimitrios Kardamakis
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 9.  [Surgical therapy of benign liver tumors].

Authors:  M Loss; C Zülke; A Obed; O Stöltzing; H J Schlitt
Journal:  Chirurg       Date:  2008-08       Impact factor: 0.955

10.  MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours.

Authors:  Maxime Ronot; Valérie Paradis; Rafael Duran; Anne Kerbaol; Marie-Pierre Vullierme; Jacques Belghiti; Dominique-Charles Valla; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2012-10-14       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.